Bayer Heart Failure Drug Cuts Death in Mid-State Trial

Ben Hirschler and Ludwig Burger, REUTERS     (REUTERS) — Bayer will move a heart failure drug into final-stage testing this year, boosting its ambitions in cardiovascular treatments after the experimental medicine showed a “striking” reduction in deaths in a mid-stage trial. Having done well Read More